Senior insider sale
Exec. Chairman & CEO at IGC PHARMA, INC. — senior position signals high conviction
$600.0K
300K shares
What this filing means
MUKUNDA RAM plans to sell 300K shares of IGC PHARMA, INC. valued at approximately $600.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/15/2024ACC: 0001185185-24-000257
DirectorOfficer10% Owner· Exec. Chairman & CEO
Since Aug 2018
300K
Shares to sell
$600.0K
Approx. market value
2.50M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Shares granted from ESOP and special grant (approved by shareholders on Sept 12, 2014)
Grants
1/7/2018
2.50MTotal acquired2.50M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/7/2018 | Shares granted from ESOP and special grant (approved by shareholders on Sept 12, 2014) Grants | 2.50M | — |
| Total | 2.50M | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
300K
Market value
$600.0K
3/15/2024
Total
Units
300K
Value
$600.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/15/2024 | 300K | $600.0K | NYSE | Planned |
| Total | 300K | $600.0K | ||